The voltage-dependent ClC-2 chloride channel has been implicated in a variety of physiological functions including fluid transport across specific epithelia. ClC-2 is activated by hyperpolarization, weakly acidic external pH, intracellular Cland cell swelling. To add more insight into the mechanisms involved in ClC-2 regulation, we searched for associated proteins which may influence ClC-2 activity. Using immunoprecipitation of ClC-2 from HEK 293 cells stably expressing the channel, followed by electrophoretic separation of coimmunoprecipitated proteins and mass spectrometry identification, Hsp70 and Hsp90 were unmasked as possible ClC-2 interacting partners. Association of Hsp90 with ClC-2 was confirmed in mouse brain. Inhibition of Hsp90 by two specific inhibitors, geldanamycin (GA) or radicicol, did not affect total amounts of ClC-2, but did reduce plasma membrane channel abundance. Functional experiments using the whole-cell configuration of the patch-clamp technique showed that inhibition of Hsp90 reduced ClC-2 current amplitude and impaired the [Cl -] i dependent rightward shift of the fractional conductance. GA and radicicol increased both the slow and fast activation time constants in a chloride-dependent manner. Heat shock treatment had opposite effects. These results indicate that association of Hsp90 with ClC-2 results in greater channel activity due to increased cell surface channel expression, facilitation of channel opening, and enhanced channel sensitivity to [Cl -] i. . This association may have important patho-physiological consequences, enabling increased ClC-2 activity in response to cellular stresses such as elevated temperature, ischemia, or oxidative reagents.
INTRODUCTION
ClC-2 is one of the nine mammalian members of the ClC chloride channel family. It is slowly activated by hyperpolarization and can be further activated by extracellular acidification or hypotonic cell swelling (25, 32, 61) . ClC-2 is expressed in many tissues, such as brain, intestine, kidney, stomach, salivary glands (for review see (31)) and heart (16) .
Although, a clear understanding of its physiological function remains to be determined, a growing body of evidence suggests that ClC-2 can play different roles depending on the tissue in which it is expressed. Disruption of the ClC-2 encoding gene in mouse leads to degeneration of male germ cells and photoreceptors, probably resulting from a defect in transepithelial transport across Sertoli cells and the retinal pigment epithelium (6) . ClC-2 may participate in fluid secretion in the murine small intestine (26) or in fluid absorption in the colon as suggested by immunolocalization (7, 35) and functional data (8) . Based on studies performed with hippocampus cells (56) or transfected DRG neurons (57) , ClC-2 has been implicated in the regulation of the effects of GABA Α receptor action by controlling intracellular chloride concentration. In humans, mutations in the gene ClCN2 that can be predicted to cause hyperexcitability of Gabaergic synapses have recently been found to be associated with idiopathic generalised epilepsies (27) .
Most of the knowledge about the gating properties of ClC channels comes from biophysical and mutational analysis of ClC-0 and ClC-1 (for review see (31)). These studies suggested a homodimeric structure of the channels with two independent protopores, recently confirmed by crystal structures of bacterial ClC homologues (18) . ClC-0 gating is controlled by two interdependent processes: a fast gate, activated by depolarization, that acts on each protopore, and a slow or common gate, activated by hyperpolarization, that controls both pores simultaneously (10, 48) . It has been proposed that the side chain of a glutamate residue within the pore serves as the protopore gate (19) , but less is known about the molecular nature of the slow gate that might involve a large conformational change as indicated by its strong temperature dependence (49). The fast gate strongly depends on voltage and external Clconcentration. This particular feature results from the effect of chloride ions on channel gating coupled to translocation of Clin the membrane electric field (11, 50) . Recent studies performed on ClC-2 transiently expressed in HEK 293 (62, 64) have shown that ClC-2 current relaxation could be described by two exponentials, probably reflecting the presence of the two gates (protopore and common gates, by analogy to ClC-0). The ClC-2 conductance (8, 15, 22, 39, 56) and the hyperpolarization-activated slow gates of ClC-0 and mutant ClC-1 (48) depend on intracellular chloride concentration ([Cl -] i ), an increase in [Cl -] i favouring channel opening. It has been suggested that the [Cl -] i and voltage-dependence and ClC-2 might arise from a voltage-dependent movement of intracellular chloride in the outward direction.
Studies on endogenous ClC-2 channels or in heterologous expression systems have shown important differences in the voltage sensitivity and activation kinetics of the current.
For example, ClC-2 activation kinetics are slower when ClC-2 is expressed in ovocytes (61) as compared to HEK 293 cells (12, 42) . Activation kinetics of endogenous currents recorded in neurons (13, 56) , T84 cells (22) , salivary glands (42) , or colonocytes (7) also differ, requiring from less than one to several seconds for steady-state activation. These observations suggest that splice variants or unknown protein partners differentiallr expressed according to the cell type may modulate channel kinetics and gating parameters.
Little is known about the existence of ClC channels partners modulating channel gating. The renal human ClC-K channel is the unique example among the ClC channel family that requires a β subunit for proper function (20) . It is reasonable to assume that additional proteins are also involved in the regulation of channel trafficking and function. For example, 5 interaction between ClC-5 and cofilin seems essential for the role of ClC-5 in albumin uptake in the proximal tubule (29) . Using the two-hybrid technology to probe the carboxy termini of ClC-2, Furukawa et al detected a direct interaction with protein phosphatase 1 (23) . By immobilization of purified intact ClC-2 on a solid phase, Dhani et al identified an interaction between ClC-2 and the retrograde motor dynein, important for regulation of ClC-2 cell surface expression (14) .
The aim of the present work was to extend the search for possible interacting partners that may modulate ClC-2 function. By means of mild lysis conditions, ClC-2 immunoprecipitation, and mass spectrometry, we found an association between ClC-2 and the two protein chaperones Hsp90 and Hsp70 in HEK 293 cells stably expressing ClC-2.
Interaction of native ClC-2 with Hsp90 was also detected in mouse brain. Hsp90 inhibition reduced plasma membrane channel expression without affecting protein stability.
Electrophysiological studies demonstrated that Hsp90 inhibition decreased ClC-2 current amplitude and decreased the sensitivity of the channel to intracellular chloride. 6 
MATERIALS AND METHODS

Constructs -
The cDNA of rat ClC-2 was kindly provided by T.J Jentsch (Hamburg, Germany). Mutagenesis was performed using recombinant PCR and sequencing. To facilitate immunoprecipitation of a large amount of ClC-2, we decided to engineer a construct containing a Flag sequence (gac tac aag gat gac gac gac aag) encoding for the Flag epitope (DYKDDDDK). Preliminary experiments were conducted to assess whether the epitope could affect channel expression or activity. Insertion of the epitope was tested in each of the four extracellular loops. Insertion was made between amino acids L132 and N133 (Loop1), K210 and E211 (Loop2), K313 and T314 (Loop3) or K400 and E401 (Loop4). Insertion of the Flag epitope in Loop1 did not significantly affect expression, localization, conductance, or voltagedependence of the channel. On the other hand, insertion in Loop3 and Loop4 markedly decreased current amplitude, and insertion in Loop2 even abolished ClC-2 current, reflecting modifications of channel activity and/or absence of surface expression. Sequences coding for WT ClC-2 or for ClC-2Flag (insertion in loop1) were subcloned in the pIRES-EGFP plasmid (Clontech, Palo Alto, USA), allowing independent expression of the two proteins EGFP and ClC-2. This expression system thus enabled us to visualize transfected cells while keeping the terminal parts of ClC-2 free.
Cells -HEK 293 cells were cultured in DMEM media supplemented with 10% serum (Gibco, Paisley, UK) at 37°C, 5% CO 2 atmosphere. Cells were transfected with linearized pIRES ClC-2, pIRES ClC-2Flag, or with empty plasmid using Lipofectamine (Invitrogen, Carlsbad, USA). Stably expressing cells were selected by adding 500µg/mL of G418 (Invitrogen, Carlsbad, USA) in the media. Isolated clones were tested for fluorescence, protein expression and ClC-2 current.
Antibodies and Drugs -Two polyclonal anti-ClC-2 antibodies were used: one raised against an N-terminal peptide (residues 1-90 of human ClC-2, H-90) purchased from Santa Cruz Biotechnology, Inc. (California, USA), and the second, homemade (35) , named pAb137, raised against a carboxy-terminal peptide (residues 847-862). The anti-Flag M2 antibodies coupled to agarose beads were purchased from Sigma-Aldrich (St. Louis, USA). Anti-GFP antibodies were from Santa Cruz Biotechnology and anti-Hsp90 (Spa-835) from Stressgen (Victoria, Canada). Geldanamycin (GA) was bought from InVivogen (San Diego, USA) and radicicol from Sigma-Aldrich (St. Louis, USA).
Immunoprecipitation and silver staining -To identify co-immunoprecipitated proteins, cells stably expressing WTClC-2 or ClC-2Flag were lysed on ice with lysis buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 10% Glycerol, 1% Triton X-100 and 0.1% IGEPAL (buffer A) complemented with anti-proteases (Roche mini tablets, Mannheim, Germany) and centrifuged at 24 000g for 60min at 4°C. Soluble protein concentration was measured using the RCDC assay from BioRad (Hercules, USA). Equal amounts of protein (200 mg) were precleared with 50 µg of a non-relevant antibody coupled to agarose beads for 60 min before adding 50 µg of anti-Flag antibodies and were incubated over-night. Beads were pelleted at 3000 g, washed 6 times with lysis buffer, and resuspended in 2x Laemli before SDS-PAGE electrophoresis separation. The mass spectrometry (30)-compatible silver staining was used for MS experiments (53). Briefly, gels were fixed in a 45% ethanol, 5% acetic acid solution, sensitized with 0.02% sodium thiosulfate and impregnated with 0.1% AgNO 3 . Staining was developed with 0.04% formaldehyde, 2% Na 2 CO 3 and the reaction was stopped with 1% acetic acid. complemented with 10mM sodium molybdate, since it has been described to stabilize Hsp90/client protein complexes (59) . Protein samples were precleared with agarose beads coupled to a non-relevant antibody and concentration was measured using the RCDC BioRad assay.
ClC-2 was immunoprecipitated from 1 mg of total extracts with 10 µg of anti-ClC-2 antibody (pAb137). Hsp90 was immunoprecipitated from 1 mg of total proteins with 5 µg of anti-Hsp90 antibodies. Non-immunizied IgG's were used as a negative control. 000 g to remove the non-soluble fraction. Agarose beads were used to pre-clear the sample, and the protein concentration was measured using the RCDC assay. 6 µg of anti-Hsp90 or non-specific rat IgG were added to equal amounts of proteins (10 mg) to precipitate Hsp90.
Precipitates were washed five times in lysis buffer, and detection of ClC-2 was performed as described above. Changes in liquid junction potential were calculated (4) and taken into account when necessary.
Pretreatment of the cells -
Currents were recorded by applying regular voltage pulses of desired length and amplitude from a holding potential of 0 mV with an interval of at least 60 s to allow current deactivation.
Time courses for activation and deactivation were described by fitting a mono-or a double-exponential plus a constant term in equations of the form: the voltage at which 50% activation occurs, and k is the slope factor.
All measured values are presented as means + S.E. Significance of differences between means was determined by unpaired t-test. The four bands indicated by arrows in Figure 1 were identified by mass spectrometry.
RESULTS
Identification of ClC-2 interacting proteins -
Samples at the same position in the control line were also analysed. ClC-2 was present in the bands at 70 kDa (68 peptides; score 2103), 90 kDa (74 peptides; score 2283), 200 kDa (77 peptides; score 2278), and in both bands above 250 kDa (56 peptides; score 2092 and 68 peptides; total score 2215), suggesting that the quaternary structure of the protein was maintained. The presence of ClC-2 at 70 kDa could be due to partial proteolysis of the protein. In addition, Hsp70 (12 peptides; score 767), Hsp90α (6 peptides; score 320) and
Hsp90β (6 peptides, score 234) were identified as co-immunoprecipitated proteins in samples at 70 kDa and 90 kDa. The access numbers were gi|228578 for ClC-2, gi|12653415 for Hsp70, gi|123678 for Hsp90α, and gi|72222 for Hsp90β. All identified proteins were absent in the control lane.
Co-immunoprecipitation of Hsp90 with ClC-2 -In this study, we focused on the interaction between ClC-2 and Hsp90. Hsp90 is an abundant cytosolic protein (accounting for 1 to 2 % of cytosolic proteins in unstressed eukaryotic cells), that functions as a molecular chaperone facilitating the folding of a variety of proteins (43) .
To rule out the possibility that the interaction of Hsp90 with ClC-2 detected by mass spectrometry could be caused by the presence of the Flag epitope, we performed immunoprecipitation of WTClC-2 using the carboxy-terminal ClC-2 antibody. Interaction between the two proteins was also tested by reverse immunoprecipitation using the anti-Hsp90 antibody. HEK 293 cells stably expressing WTClC-2 or the empty plasmid as a control were lysed using buffer A containing 10 mM sodium molybdate. Samples were thoroughly precleared with non-relevant antibodies coupled to agarose beads and the immunoprecipitated partner was probed using the appropriate antibody. As shown in the left panel of Figure 1B To determine whether this interaction existed in vivo, the same experiments were repeated using mouse brain homogenates known to express high levels of ClC-2. Protein extracts were incubated with the anti-Hsp90 antibody, and immunoprecipitated proteins were as an index of protein loading ( Figure 2A ). Inhibition of Hsp90 activity did not significantly affect the amount of ClC-2 in the total cell extracts (n=3).
Since interaction of Hsp90 with client proteins may influence protein trafficking (44), we further investigated whether Hsp90 inhibition could modify the distribution of ClC-2 using an immunolabeling approach. As shown in Figure 2B , the pattern of ClC-2 staining was quite similar between untreated and treated cells except that membrane staining was less visible. However, the faint and non-uniform membrane staining in control cells did not allow an accurate comparison of the amount of ClC-2 at the membrane. A more quantitative analysis was performed using cell surface proteins isolated with the biotinylation procedure.
Western blotting of membrane proteins showed that treatment by GA significantly decreased the overall amount of ClC-2 present in the bands at 200 kDa and 90 kDa ( Figure 2C ), by 39.1 ± 9 %, n=4, with respect to control cells ( Figure 2D ).
Functional assay for ClC-2/Hsp 90 interaction: effect of geldanamycin and radicicol on ClC-2 current -We performed whole-cell patch-clamp studies to investigate whether there was any functional evidence for ClC-2/Hsp90 interaction in HEK 293 cells stably expressing ClC-2. As previously described (12, 42) , Figure 3B ) showed that maximal inhibitory effects of the two inhibitors were obtained within the same range of concentrations needed for inhibition of ATP hydrolysis (51). We observed that the extent of current inhibition varied according to the chloride concentration in the pipette solution. Current recordings before and after GA treatment, at 15 and 135 mM internal Clare shown in Figure   3C and 3D, respectively. At 15 mM internal Cl -, current amplitude decreased by 36.9 ± 4.3% Figure 2C,D) , part of the current inhibition was probably linked to a decrease in the amount of ClC-2 channels at the plasma membrane. However, the differential current inhibition according to the value of [Cl -] i suggested that GA could additionally modulate [Cl -] i -dependent gating parameters.
Activation of ClC-2 channels is known to depend on both the membrane potential and intracellular chloride concentration (8, 15, 22, 27, 39, 56) . Figure 4A Figure 4C) . The values for V 0.5 at different [Cl -] i are plotted in Figure 4D . The effect of GA was chloride-dependent so that the slope of V 0.5 vs.
[Cl -] i became less steep with respect to that for untreated cells ( Figure 5G ). Thus, in the presence of GA, opening of the channels required more negative potentials for [Cl -] i higher than 15 mM. The change in the slope of V 0.5 vs. [Cl -] i first suggests that GA did not simply increase the intrinsic energy difference between the open and closed states but also altered parameters involved in the chloride sensitivity of current activation. In addition, this change could explain why current inhibition in the presence of GA was greater for the highest internal Clconcentrations ( Figure 3D) Effect of geldanamycin on current activation and deactivation kinetics -In previous studies, ClC-2 current relaxations have been described by two exponentials, probably reflecting the presence of two gates (12, 62) . We thus examined whether GA affected both or preferentially one of the two components of current activation.
Activation time constants measured at -120mV as a function of [Cl -] i, are plotted in increased at the expense of the proportion of the slow phase, (As) ( Figure 5C and D, white bars). GA treatment attenuated the chloride-dependent decrease of the slow time constant of current activation and completely prevented the decrease of the fast one ( Figure 5A ). The relative proportions of the two components were not affected up to 100 mM Cl -( Figure 5B and C, black bars), but at 135mM GA decreased by half the fractional amplitude of A 0 while increasing the weight of As. (compare Figure 5C and D) .
Deactivation at positive potentials was well described by two exponential time courses even at low chloride concentrations ( Figure 5E ), implying that current deactivation was not strictly the reverse process of current activation. Increasing [Cl -] i did not markedly change the time constants of deactivation between 15 and 100 mM Cl -, whereas at 135 mM Cl -, the slow time constant was slightly but significantly increased ( Figure 5E, p<0 .05) and deactivation was not complete as revealed by the presence of a sizeable non-closing fraction (A 0 ) ( Figure   5H , white bar). Deactivation was less affected than activation by GA. The slow time constant of deactivation was slightly decreased ( Figure 5E ), whereas the fast component remained unchanged. In agreement with the results described above, the time independent fraction of the current at 135 mM internal Clwas markedly decreased by GA application (Figure 5H Figure 6A , the Hsp90 signal increased progressively during the first hours of recovery, and a two fold increase (n=2) was detected after 6 hours recovery at 37°C, (n=2). This increase was not accompanied by significant changes of ClC-2 in wholecell extracts nor in the amount of ClC-2 at the membrane (not shown).
To determine whether heat shock treatment could affect ClC-2 gating parameters, we measured ClC-2 using a 35 mM Clpipette solution. Figure 6B illustrates currents recorded during a hyperpolarizing jump to -120 mV in basal conditions or after a one-hour thermal stress followed by 6 hours recovery. As visible on the current traces, heat shock treatment increased the macroscopic rate of current activation by decreasing by around two fold the slow time constant ( Figure 6C ) without significantly changing the rate of current deactivation ( Figure 6D) . These effects were accompanied by a shift of V 0.5 from -116.5 ± 2.7 mV (n=12)
to -106.8 ± 2.7 mV (n=7) that reached statistical significance (p=0.038).
DISCUSSION
In the present study, we have identified two heat shock proteins, Hsp70 and Hsp90, that co-immunoprecipitate with ClC-2 stably expressed in HEK 293 cells, and we provide evidence for a similar association in mouse brain. Pharmacological experiments designed to disrupt the association between Hsp90 and the channel protein showed that Hsp90 does not affect ClC-2 stability but favours cell surface expression. Patch-clamp experiments demonstrated that interaction between both proteins up-regulates the chloride conductance by shifting the voltage dependence of channel opening to less negative potentials and by increasing the sensitivity of the channel to [Cl] i .
Hsp70 is described to play an important role in protein folding, quality control, and in membrane translocation processes (55). Hsp90 may also have a role in nascent chain folding but is best known to control the conformational maturation and the activity of a variety of proteins within multichaperone complexes comprising Hsp70, immunophilins, p23 and Hop (43) . Hsp90 client proteins include steroid hormone receptors, transcription factors, various protein kinases and phosphatases (43) . Apart from signalling proteins, Hsp90 has also been shown to interact with a number of plasma membrane receptors (1, 60, 63) and ion channels (21, 36) .
Co-immunoprecipitation of Hsp70 along with Hsp90, suggests an interaction with
ClC-2 in a large complex which probably involves co-chaperone partners. We have not yet performed more investigations to test for the presence of such partners. Since the expression of co-chaperones may differ among cells and tissues, it would be interesting to analyse whether differentially represented co-chaperones could contribute to the variability of the gating properties of ClC-2 between endogenous channels and channels expressed in ovocytes or cell lines.
The molecular basis underlying the interaction between Hsp90 and ClC-2, either direct or indirect, remains to be determined. Some chaperone client proteins contain a tetratricopeptide motif (TPR) which binds to an acceptor site in the C-terminus of Hsp90 (47) but such a motif is absent from the ClC-2 sequence. In any case, little is known regarding the mechanism by which Hsp90 binds to substrates in the absence of TPR motifs (45) . It must be recognized that an indirect interaction through an unknown ClC-2 partner cannot be excluded.
Among others, a possible candidate is dynein which has already been demonstrated to associate with ClC-2 (14) and is also known as an Hsp90 client protein in other systems (24, 38) . However, we could not identify dynein in any band size analysed. The contribution of dynein could also be questioned from the inhibitory effects of GA and radicicol on cell surface ClC-2 expression. The role of Hsp90 and immunophilins in protein trafficking has been particularly well examined for the glucocorticoid receptor and the tumour suppressor p53 (44) , requiring assembly of these proteins with the motor protein dynein. Dhani et al reported that pharmacological inhibition of dynein increased the expression of ClC-2 at the plasma membrane (14) . Hence, the possible disruption of Hsp90/dynein interaction by GA might produce the same effect which can be in agreement with the transient increase of current amplitude induced by the two Hsp90 inhibitors but not with the reduced amount of ClC-2 at the plasma membrane following prolonged exposure. ClC-2 trafficking to the plasma membrane has also been shown to be modulated by anterograde or retrograde vesicular transport involving PI3kinase (2), the glucocorticoid inducible kinases SGKs and the ubiquitin ligase Nedd4-2 (41) . Since Hsp90 has been shown to be involved in eNOs translocation to the apical membrane in a PI3kinase dependent manner (40) , it would be interesting to investigate whether a similar mechanism exists for ClC-2 and Hsp90.
We found no evidence of ClC-2 degradation following Hsp90 inhibition, implying that association between the two proteins does not involve the well established role of Hsp90 as a chaperone implicated in client protein maturation. The functional consequences of pharmacological inhibition of Hsp90 or heat shock treatment are rather reminiscent of the role for tyrosine phosphorylated Hsp90 as a repressor of the purinergic P2x7 receptor function (1) or as a modulator of the NKCC transporter (54) without modifications of the expression level of these two proteins.
Functional experiments demonstrated that GA and radicicol decreased current amplitude. ClC-2 activity can be modulated by phosphorylation or dephosphorylation events (22) and more directly by p34 cdc2 /cyclinB and the protein phosphatase PP1 (23) . (12) . We checked whether the latter difference could be linked to the experimental protocols, conventional (62) or nystatin perforated whole cell patch-clamp recordings (this work). Recordings performed with the two methods indicated that current activation displayed a mono-exponential time course when using pipette solutions with low [Cl -] i . Since at the same [Cl -] i . we could consistently extract two gating processes from deactivation currents, it is reasonable to assume that the weight of the fast process was too weak during activation to be detected in our experiments. The reason for this discrepancy is unclear. It is possible that the mode of ClC-2 expression, transient in the previous works (12, 62) or stable in the present study, may influence basal regulation of channel gating. Since GA treatment did not affect the voltage-dependence of current activation at low chloride concentrations nor the apparent gating charge whatever the [Cl -] i , the most likely explanation for the decreased sensitivity to [Cl -] i was a change in the apparent affinity for chloride binding. Considering that gating of the channel probably involves conformational changes of the protein (64) and that Hsp90 usually helps conformational changes of its partners, it is tempting to speculate that the chaperone favours an optimal channel conformation for ion binding and/or movement through the pore.
It is evident that such an hypothesis can be raised only if a direct interaction exists between the two proteins. Despite this concern, our observations have brought to light a new regulatory element which may be important for the [Cl -] i sensitivity of channel gating thought to provide a mechanism for coupling of Clfluxes across apical and basolateral membranes in epithelia (8) . Within this context, it is interesting to note that the recently reported interaction between Hsp90 and the co-transporter NKCC may play an important role for the [Cl -] i dependence of the transporter (54) . Modulation of ClC-2 function by Hsp90 may be of pathophysiological importance linking Hsp90 stimulators such as elevated temperature, oxidative stress or ischemia to channel activation. It is noteworthy that recovery of barrier function in ischemia-injured ileum requires chloride secretion through ClC-2 channels (37) . It has also been suggested that in the heart, an increase in ClC-2 conductance could be pro-arrhytmic under some pathological conditions such as ischemia and hypoxia (17, 33) . Moreover, oxidation has been shown to potentiate the activation of ClC-2 channels by cell swelling in Plasmodium Falciparum infected erythrocytes (30) . Even though oxidants have been shown to exert a rapid and possible direct effect on ClC-2 expressed in Xenopus ovocytes, it cannot be excluded that ClC-2 activation in infected erythrocytes may additionally involve recruitment of the host chaperones to the plasma membrane (3) . Along with CFTR and NKCC1, ClC-2 thus represents the third class of chloride transport systems modulated by
Hsp90, suggesting a key role for the chaperone in the regulation of cell volume and epithelial secretory or absorptive functions.
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